RNAZ

TransCode Therapeutics Inc

May 15 • 04:00PM ET

6.60

-0.19 -2.78 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN BCDA SHPH HOTH ARTL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-97.53	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	-9.84%
Market Cap	6.27M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.83M	Perf Month	-24.14%
Enterprise Value	130.00M	PEG	-	EPS next Q	-	Inst Own	6.59%	Short Float	4.31%	Perf Quarter	-28.34%
Income	-36.27M	P/S	-	EPS this Y	-	Inst Trans	3.79%	Short Ratio	3.41	Perf Half Y	-25.00%
Sales	0.00M	P/B	0.59	EPS next Y	-	ROA	-40.85%	Short Interest	0.04M	Perf YTD	-3.37%
Book/sh	11.27	P/C	0.35	EPS next 5Y	-	ROE	-46.26%	52W High	20.99 -68.56%	Perf Year	-13.73%
Cash/sh	18.75	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-22.82%	52W Low	6.08 8.50%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.19% 7.16%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	93.85%	Oper. Margin	-	ATR (14)	0.60	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.29	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	26.72	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.29	EPS Q/Q	89.80%	SMA20	-16.04%	Beta	1.38	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-22.78%	Rel Volume	0.61	Prev Close	6.79
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-32.36%	Avg Volume	10.49K	Price	6.60
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	6,369	Change	-2.78%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)